Coloplast A/S B Stock News
kr412.50
0.67%
Copenhagen, Oct 02, 04:59 pm CEST.
Closed.
Industry
Coloplast A/S B Stock News
Medical equipment maker Coloplast expects its Kerecis wound-care business to return to growth from January 2027 after changes to U.S. Medicare payments caused sales in outpatient settings to fall sharply, its finance chief told Reuters on Tuesday.
The global leader within intimate healthcare today announced FDA approval of Titan Prime, an inflatable penile prosthesis (IPP) that represents the company's next-generation device and will be available in the U.S. in late 2026.
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
